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Background/aim: To evaluate the protective effect of melatonin on ovarian ischemia reperfusion injury in a rat model.
Materials and methods: Forty-eight rats were separated equally into 6 groups. Group 1: sham; Group 2: surgical control with 3-h
bilateral ovarian torsion and detorsion; Group 3: intraperitoneal 5% ethanol (1 mL) just after detorsion (as melatonin was dissolved in
ethanol); Group 4: 10 mg/kg intraperitoneal melatonin 30 min before 3-h torsion; Group 5:10 mg/kg intraperitoneal melatonin just after
detorsion; Group 6:10 mg/kg intraperitoneal melatonin 30 min before torsion and just after detorsion. Both ovaries and blood samples
were obtained 7 days after detorsion for histopathological and biochemical analysis.
Results: In Group 1, serum levels of total oxidant status (TOS) (μmol H2O2 equivalent/g wet tissue)were significantly lower than in
Group2 (P = 0.0023), while tissue TOS levels were lower than in Group 3 (P = 0.0030). Similarly, serum and tissue levels of peroxynitrite
in Group 6were significantly lower than those ofGroup 2 (P = 0.0023 and P = 0.040, respectively). Moreover, serum oxidative stress
index (OSI) (arbitrary unit) levels were significantly increased in Group 2 when compared to groups 1 and 6 (P = 0.0023 and P= 0.0016,
respectively) and in Group 3 with respect to groups 1, 4, 5, and 6 (P = 0.0023, P = 0.0026, P = 0.0008, and P = 0.0011, respectively).
Furthermore, there was a significant decrease in histopathological scores including follicular degeneration, vascular congestion,
hemorrhage, and inflammation in the melatonin and sham groups in comparison with control groups. Additionally, primordial follicle
count was significantly higher in Group 6 than in Group 2 (P = 0.0002).
Conclusion: Melatonin attenuates ischemia reperfusion damage in a rat torsion/detorsion model by improving histopathological and
biochemical findings including OSI and peroxynitrite.
Key words: Ischemia reperfusion injury, rat ovarian torsion, melatonin, oxidative stress index, peroxynitrite

1. Introduction
Twisting of the ovary along with the fallopian tube is
referred to as adnexal torsion; it may affect females of all
ages, particularly women of reproductive age from 20 to
40 years of age [1]. The most common symptom of ovarian
torsion is acute onset of lower abdominal pain, followed by
nausea and vomiting. It presents clinically as a gynecologic
surgical emergency and often compromises ovarian
lymphatic and blood supply. Therefore, urgent diagnosis
and treatment is crucial to preserve ovarian function
and to prevent other related morbidities in patients with
ovarian torsion.

The most common method of treatment is laparoscopy,
and the main objective of the intraoperative evaluation is to
confirm the diagnosis of torsion and evaluate the viability
of the ovarian tissue. Most twisted ovaries are considered
potentially viable and can be preserved by detorsion unless
there is an ovarian mass with suspicionof malignancy or
the patient is postmenopausal, in which casesalpingooophorectomy is performed [2]. The blood supply to the
twisted ovary is sufficient for survival of follicles despite its
necrotic black bluish appearance [3].
Untwisting of the twisted ovary reestablishes the
blood supply; however, the return of blood flow can also
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result in further ovarian damage and complications,
termed ischemia reperfusion injury [4]. Recently, many
pharmacological agents have been found to alleviate the
effects of ischemia reperfusion injury in animal models,
due to their antioxidant and antiinflammatory effects [5–
8].
Melatonin
(5
methoxy-N-acetyltryptamine),
discovered and isolated from bovine pineal gland by
Aaron Lerner in 1958,is produced in many organs, mainly
by the pineal gland [9,10]. The circadian production of
melatonin explains its regulatory action on circadian
rhythms such as body temperature or sleep-wake cycles
and neuroendocrine rhythms [11,12]. Moreover, it has
antioxidant and antiinflammatory properties and critical
effects on many diseases, including asthma [13], diabetic
retinopathy [14), depression [15], infection [16], and
endometriosis [17]. However, there have been only 3
studies in the literature showing preventive effects of
melatonin on ischemia reperfusion injury of the rat ovarian
torsion/detorsion model [18–20]. In addition, it has also
been investigated in cat ovarian [21] and rat uterine [22]
torsion/detorsion models.
The objective of this study was to investigate the
effectiveness of melatonin in preventing ovarian ischemia
reperfusion injury in a rat model through biochemical and
histopathological analysis.
2. Materials and methods
2.1. Animal care
A total of 48 female adult Wistar albino rats weighing
150–250 g and aged 10–15 weeks were included in this
study, which was performed at the Hacettepe University
Department of Physiology Animal Research Laboratory.
All experimental procedures were carried out once the
study protocol was approved by the Hacettepe University
Ethical Committee on Animal Research (Approval No.
2019/08-02), with a commentary advising that both the
sham and surgical control groups (16 rats in total) should
be the used in another similar study of ours (unpublished)
performed at the same time period to decrease the number
of rats used. The animals were fed ad libitum and kept in
a temperature and humidity-controlled environment (22
± 2 °C) with a cycle of 12 h of darkness followed by 12 h
of light.
2.2. Surgical procedures and groups
Animals were allocated randomly into 6 groups. Group 1
(n = 8, sham group): the abdominal wall was kept open for
3 h and then closed. Ovarian torsion was not performed.
Rats were followed-up for 1 week after the first operation
without any medication. Group 2 (n = 8, torsion/detorsion
+ control group): bilateral ovarian torsion was performed;
3 h after ischemia, detorsion was applied. No treatment
agent was given to the rats during the follow-up period of 1
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week. Group 3 (n = 8, torsion/detorsion + ethanol group):
bilateral ovarian torsion was performed; 3 h after ischemia,
detorsion was applied. A single dose of 1-mL 5% ethanol
solution was given intraperitoneally (i.p.) to all rats just after
detorsion and administered daily for 1week (as melatonin
was dissolved in ethanol solution, it was aimed to see the
effects of ethanol itself on ischemia reperfusion injury in
Group 3).Group 4(n = 8, torsion/detorsion + melatonin
prophylaxis only group): 30 min before the induction of
ovarian torsion, rats were given a single dose of 10 mg/kg
i.p.melatonin (melatonin powder, Alfa Aesar GmbH & Co
KG, Karlsruhe, Germany). No maintenance treatment was
applied after detorsion or during the follow-up period of
1 week. Melatonin in dry powder form was dissolved in
99% ethanol and then diluted in saline just before injection
with final ethanol and melatonin concentrations of 5%and
10 mg, respectively, per mL,as in our previous studies
[17]. Group 5 (n = 8, torsion/detorsion + melatonin
prophylaxis plus maintenance group): a dosage of 10 mg/
kg i.p. melatonin was given to each rat 30 min before
the induction of ovarian torsion, and repeated just after
detorsion preceding 3 h of ischemia. A 10 mg/kg i.p. dose
of melatonin was administered daily for 1 week. Group 6
(n = 8, torsion/detorsion + melatonin maintenanceonly
group): a single dose of 10 mg/kg i.p. melatonin was
administered to each rat just after the ovarian detorsion
preceding 3 h of ischemia, and repeated daily during the
1-week period, postoperatively.
Rats were anesthetized withan i.p. injection of a
combination of ketamine hydrochloride (50 mg/kg
Ketalar; Eczacıbaşı Holding, İstanbul, Turkey) and
xylazine hydrochloride (10 mg/kg Rompun; Bayer Türk
Kimya Sanayii Ltd. Şti., İstanbul, Turkey).Once the
abdomen was shaved and prepared with a povidoneiodine scrub, a laparotomy was performed by making a
2-cm longitudinal incision in the midline area of the lower
abdomen, and the uterine horns and adnexa were viewed.
Ischemia was induced for 3 h using a torsion model
conducted by applying and rotating atraumatic vascular
clips 360° clockwise to the vascular pedicle 1 cm above
and below each ovary bilaterally. The abdominal wall
including muscle aponeurotic plane and skin was sutured
with 3-0 Vicryl (polyglactin 910, Ethicon, Inc., Somerville,
NJ, USA). Bilateral oophorectomy was carried out 1week
after the first surgery in all groups for histological scoring
(right ovaries) and biochemical evaluation (left ovaries).
A 1-mL blood sample was obtained from the vena cava
of each rat for the measurement of biochemical markers.
After the completion of the overdose of anesthetic drugs,
all rats were sacrificed.
2.3. Histopathological examinations
Ovarian tissues were fixed in 10% formalin for 48 h.
After fixation, the tissues were prepared using standard
procedures and embedded in paraffin. Serial 5-μm
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sections were cut from ovary blocks with a microtome and
stained with hematoxylin–eosin. For each specimen, all
sections were analyzed using a light microscope with 10×
magnification (Olympus BX46; Olympus Corporation,
Tokyo, Japan). Ovarian damage, including follicular
cell degeneration, vascular congestion, hemorrhage,
and inflammation (neutrophil infiltration), was scored
histologically using a graduated scale (0 = none; 1 = mild;
2 = moderate; 3 = severe).Total scores were calculated
according to these parameters. Evaluation was performed
by a pathologist who was blind to the study groups.
2.4. Biochemical analysis
Total antioxidant status (TAS) and total oxidant status
(TOS) levels were measured using a colorimetric method
applied by Erel [23]. The results are expressed in millimoles
Trolox equivalent/L (mmol Trolox equivalent/g wet tissue)
for TAS, and micromolar hydrogen peroxide (H2O2)
equivalent per liter of TOS (μmol H2O2 equivalent/g wet
tissue) [24].The ratio of TOS to TAS was accepted as
oxidative stress index (OSI). For calculation, the miilimole
TAS unit was first converted to a micromole unit. OSI
value was calculated according to the following formula:
OSI (arbitrary unit) = [TOS μ mol H2O2 equivalent/gr
protein)/TAS μ mol Trolox equivalent/gr protein × 10]. The
peroxynitrite assay and protein content were determined,
as previously described [25,26]. The results were expressed
as micromole/L for serum and micromole/g for wet tissue,
respectively. Biochemical measurements were carried out
using a spectrophotometer (Shimadzu U 1601, Shimadzu
Corp., Kyoto, Japan).
2.5. Statistical analysis
The IBM Statistical Package for the Social Sciences (SPSS),
version 24.0 (IBM Corp., Armonk, NY, USA) was used
for statistical analysis. A two-tailed Pvalue of <.05 was
considered significant. The mean, standard deviation,
median (interquartile range), and sample size values for
the variables are presented in the tables. The normality
of the distribution of the variables was tested with the
Shapiro–Wilk test. The homogeneity of the variances of the
groups was tested with Levene’s test. Parametric variables
were compared by one-way ANOVA, followed by Tukey’s
HSD test. The multigroup comparison of nonparametric
variables was conducted using the Kruskal–Wallis test
with a two-tailed P-value significance threshold of 0.05.
Pairwise comparisons were conducted using the Mann–
Whitney U-test with Bonferroni correction. The correction
was carried out by dividing the significance value of 0.05
by the total comparison number of the group, leading to a
new adjusted significance level of 0.05/15 = 0.003.
3. Results
With 8 rats in each of the 6 groups, a total of 48 rats were
involved in the study. One rat in Group 4 died during the

study. The macroscopic appearance of surgical procedures
of rat ovarian torsion/detorsion model was as shown in
Figure 1: Ovaries just before (1a) and after torsion (1b),
and just before (1c) and 1 week after (1d) detorsion.
The comparison of TAS, TOS, OSI, and peroxynitrite
tissue levels between the sham (Group 1), surgical control
(Group 2), ethanol control (Group 3), and melatonin
treatment (Groups 4, 5, and 6) groups are shown in Table 1.
Although tissue TAS, TOS, and OSI levels were improved
in treatment groups, they did not differ significantly
between the treatment and control groups. However,
tissue levels of TOS in Group 1 compared to Group 3 (P =
0.0030) and peroxynitrite in Group 6 compared to Group
2 were significantly lower (P = 0.0040).
Table 2 shows the comparison of serum TAS, TOS, OSI,
and peroxynitrite levels among the groups. Group 2 had
significantly higher serum levels of TOS and peroxynitrite
than Groups 1 and 6 (both P = 0.0023). Moreover, serum
OSI levels were significantly increased in Group 2 when
compared to Groups 1 and 6 (P = 0.0023 and P = 0.0016,
respectively), and in Group 3 compared to Groups 1, 4, 5,
and 6 (P = 0.0023, P = 0.0026, P = 0.0008 and P = 0.0011,
respectively).
Table 3 shows the comparison of histopathological
scores for ovarian damage between the groups. All scores
were significantly lower in Group 1 than in almost all
other groups. Moreover, there were significant increase
in histopathological scores of control groups regarding
hemorrhage (Group 2 vs. Group 5: P = 0.0008; Group 3
vs. Groups 4, 5, and 6: P = 0.0014, P = 0.0002, P = 0.0008,
respectively), congestion (Group 3 vs. Groups 5 and 6:
P = 0.0008 and P = 0.0028, respectively) and follicular
degeneration (Group 2 vs. Group 5: P = 0.0013, and Group
3 vs. Group 5: P = 0.0032) with respect to treatment groups.
Table 4 shows the comparison of rat ovarian follicle
counts between control and melatonin-treated groups.
Primary, secondary, and tertiary follicle counts tend to
be higher in the sham (Group 1) and melatonin-treated
groups (Groups 4, 5, and 6) when compared to the
surgical control rats (Group 2), but the difference was
not statistically significant. However, primordial follicle
count was statistically significantly higher in Group 6 in
comparison with Groups 2 (P = 0.0002), 3 (P = 0.0005), 4
(P = 0.0012), and 5 (P = 0.0027).
Figure 2 shows histological sections of rat ovaries.
Vascular congestion, hemorrhage, and edema were normal
in the sham group (2a), much increased in the surgical
control group (2b), and mildly increased inthe melatonin
group (2c). Similarly, follicular degeneration was absent
in the sham group (2d), much increased in the surgical
control group (2e), and mildly increased in the melatonin
group (2f).
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Figure 1. Surgical steps of addressing rat ovarian torsion model: a) rat ovary just before torsion, b) rat ovary just after torsion using
bulldog vascular clamps, c) rat ovary with black-bluish appearance just before detorsion proceeding 3 h of ischemia, d) rat ovary 1
week after the detorsion.

4. Discussion
The present study focused on the effects of melatonin on
ovarian ischemia reperfusion injury in a surgically-induced
torsion/detorsion model of rats by modulating oxidant
and antioxidant status. At the end of the study, it was
found that melatonin signiﬁcantly decreased the ischemia
reperfusion injury of the ovary both histopathologically
and biochemically. There were signiﬁcant reductions in
both tissue and serum levels of peroxynitrite, while serum
OSI level was signiﬁcantly decreased in the melatonin
group when compared to control rats. Moreover,
primordial follicle count was statistically significantly
higher in the melatonin-treated group than in the
surgical control group. Furthermore, histopathological
analysis showed that the ovaries of the rats treated with
melatonin had signiﬁcantly lower hemorrhage, follicular
degeneration, and total tissue damage scores than those of
rats in the control groups.
Ovarian torsion is a painful gynecologic emergency
with a prevalence of about 3%; arterial or venous blockage
may come out in the adnexa as a result of this rotation.
Immediate detorsion is the main treatment to solve
ischemia and establish reperfusion. Ovarian ischemia
and reperfusion during the torsion/detorsion process may
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cause oxidative stress through overproduction of ROS in a
pathologic amount. Reperfusion injury after detorsion has
been reported to be related with excessive release of oxygen
species [27,28]. Thus, prevention of ovarian damage
caused by ischemia reperfusion injury is important in the
area of gynecology.
Numerous therapeutic agents showing antioxidant
actions have been studied for protective effects against
ovarian ischemia reperfusion injury rat models [29–
32]. Melatonin, an endogenous indolamine related to
circadian rhythms, has proven itself as an essential agent
against toxic free radicals and provides a strong defense
against ischemia reperfusion injury [33,34]. It was found
in our previous study that melatonin caused regression of
endometriotic implants in rats by improving antioxidation
actions on superoxide dismutase and malondialdehyde
[17].
TAS and TOS reﬂect the total effects of all antioxidants
and oxidants in the plasma, body ﬂuids, or tissues,
respectively [23]. OSI is calculated with the formula of
TOS/TAS and is regarded as a more appropriate index of
oxidative stress on the plasma or tissue. Several antioxidant
free radical scavengers have been shown to prevent
ovarian ischemia reperfusion injury in rats by improving
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Table 1. Comparison of tissue TAS, TOS, OSI, and peroxynitrite levels between control and melatonin treated groups.
TAS

TOS

OSI

Peroxynitrite

Group 1 (n: 8)

8.04 ± 1.36

83.59 ± 14.61

1.08 ± 0.34

38.18 ± 8.07

Group 2 (n: 8)

8.43 ± 1.83

114.80 ± 27.07

1.41 ± 0.38

45.34 ± 5.70

Group 3 (n: 8)

9.30 ± 2.65

120.38 ± 25.75

1.40 ± 0.58

44.15 ± 3.37

Group 4 (n: 7)

10.34 ± 1.12

106.89 ± 21.48

1.05 ± 0.25

34.77 ± 8.59

Group 5 (n: 8)

10.46 ± 1.76

100.02 ± 21.13

0.97 ± 0.24

35.20 ± 8.44

Group 6 (n: 8)

10.63 ± 1.83

108.20 ± 15.22

1.05 ± 0.23

34.01 ± 8.63

P-value

0.024a

0.029b

0.056b

0.009a

Values are presented as mean ± SD, median (interquartile range), T: tissue, TAS: total antioxidant status, TOS: total oxidant status; OSI:
oxidative stress index, n; number
Units of ovarian tissue TAS: millimol Trolox Eq/gr, TOS: micromol H2O2 Eq/gr, OSI: arbitrary unit, and Peroxynitrite: micromol/gr.
P-values were calculated with aone-way ANOVA or bKruskal–Wallis test. The significant pairwise group comparison results were as
represented below:
For TAS: no significant pairwise comparison (post hoc test: Tukey HSD).
For TOS: 1 vs. 3: P = 0.0030 (Mann–Whitney U test with Bonferroni correction).
For peroxynitrite: 2 vs. 6: P = 0.040 (post hoc test: Tukey HSD)
Table 2. Comparison of serum TAS, TOS, OSI, and peroxynitrite levels between control and melatonin treated groups.
TAS

TOS

OSI

Peroxynitrite

Group 1 (n: 8)

1.12 ± 0.13

10.37 ± 6.80

0.96 ± 0.67

0.85 ± 0.20

Group 2 (n: 8)

1.04 ± 0.07

26.64 ± 10.12

2.56 ± 1.01

1.28 ± 0.24

Group 3 (n: 8)

1.21 ± 0.42

9.12 ± 8.02

2.71 ± 0.56

1.16 ± 0.28

Group 4 (n: 7)

1.03 ± 0.07

24.31 ± 7.10

1.07 ± 0.52

0.75 ± 0.39

Group 5 (n: 8)

1.18 ± 0.07

14.68 ± 7.82

0.94 ± 0.36

0.91 ± 0.38

Group 6 (n: 8)

1.24 ± 0.20

13.99 ± 9.41

0.72 ± 0.49

0.60 ± 0.34

P-value

0.009

0.002

<0.001

0.002

Values are presented as mean ± SD, median (interquartile range), T: tissue, TAS: total antioxidant status, TOS: total oxidant status; OSI:
oxidative stress index, n; number
Units of serum TAS: millimol Trolox Eq/L, TOS: micromol H2O2 Eq/L, OSI: arbitrary unit and Peroxynitrite: micromol/L.P-values for
multigroup comparisons were calculated with Kruskal–Wallis. The significant pairwise group comparison results were as represented
below: (post hoc test: Bonferroni correction)
For TAS: 4 vs. 5: P = 0.0026.
For TOS: 1 vs. 2: P = 0.0023.
For OSI: 1 vs. 2: P = 0.0023, 1 vs. 3: P = 0.0023, 2 vs. 6: P = 0.0016, 3 vs. 4: P = 0.0026, 3 vs. 5: P = 0.0008, 3 vs. 6: P = 0.0011.
For peroxynitrite: 2 vs. 6: P = 0.0023.

TAS, TOS, and OSI [35,36]. Peroxynitrite (ONOO–)
is the major component of nitroxidative stress. When
reactive nitrogen species are overproduced, nitric oxide
(NO•) reacts quickly with the superoxide radical (O2•–)
to form peroxynitrite (ONOO–), which is itself cytotoxic,
and then easily decomposes into toxic hydroxyl radical
(OH •) and nitrogen dioxide. As peroxynitrite exerts its
cytotoxic action thru mitophagy, inhibiting peroxynitritemediated mitophagy activation improves ischemia
reperfusion injury [37,38]. Moreover, melatonin as an

antioxidant improves TOS, TAS, OSI, and peroxynitrite,
as demonstrated in previous studies [39–41].
To the best of our knowledge, protection of the rat
ovary from ischemia reperfusion injury using melatonin
has been investigated in only 3studies up to date. In thefirst
study, histopathological scores and malondialdehyde were
significantly improved by melatonin in a rat torsion/
detorsion model [18]. In the second study, melatonin
(10 mg/kg i.p. for 3 h) was found to protect the ovaries
against oxidative damage associated with reperfusion
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Table 3. Comparison of histopathological scores of ovarian damage between control and melatonin treated groups.
Hemorrhage

Congestion

Follicular
degeneration

Inflammation

Group 1 (n: 8)

0.00 ± 0.00

1.00 ± 0.00

0.13 ± 0.35

0.13 ± 0.35

Group 2 (n: 8)

1.88 ± 0.35

1.88 ± 0.64

2.38 ± 0.74

2.75 ± 0.46

Group 3 (n: 8)

2.13 ± 0.35

2.13 ± 0.35

2.00 ± 0.76

3.00 ± 0.00

Group 4 (n: 7)

1.14 ± 0.38

1.29 ± 0.76

1.00 ± 0.58

2.00 ± 0.82

Group 5 (n: 8)

0.88 ± 0.35

1.13 ± 0.35

0.75 ± 0.46

1.88 ± 0.83

Group 6 (n: 8)

1.13 ± 0.35

1.25 ± 0.46

1.13 ± 0.64

1.88 ± 1.13

P-value

<0.001

<0.001

<0.001

<0.001

Values are presented as mean ± SD, median (interquartile range), n: number.
P-values were calculated with Kruskal–Wallis. The significant results by pairwise group comparison using Mann–Whitney U test with
Bonferroni correction were as represented below:
For hemorrhage: 1 vs. 2: P = 0.0001, 1 vs. 3: P = 0.0001, 1 vs. 4: P = 0.0002, 1 vs. 5: P = 0.0006, 1 vs. 6: P = 0.0001, 2 vs. 5: P = 0.0008, 3
vs. 4: P = 0.0014, 3 vs. 5: P = 0.0002, 3 vs. 6: P = 0.0008.
For congestion: 1 vs. 2: P = 0.0031, 1 vs. 3: P = 0.0001, 3 vs. 5: P = 0.0008, 3 vs. 6: P = 0.0028.
For full degeneration: 1 vs. 2: P = 0.0005, 1 vs. 3: P = 0.0006, 2 vs. 5: P = 0.0013, 3 vs. 5: P = 0.0032.
For inflammation: 1 vs. 2: P = 0.0003, 1 vs. 3: P = 0.0001, 1 vs. 4: P = 0.0009, 1 vs. 5: P = 0.0007, 1 vs. 6: P = 0.0027.
Table 4. Comparison of ovarian follicle count between control and melatonin treated groups.
Primordial

Primary

Secondary

Tertiary

follicle count (n)

follicle count (n)

follicle count (n)

follicle count (n)

Group 1 (n: 8)

8.3 ± 3.4

5.9 ± 3.8

4.5 ± 1.6

8.4 ± 2.7

Group 2 (n: 8)

4.8 ± 1.5

3.9 ± 1.6

3.4 ± 1.7

3.6 ± 2.5

Group 3 (n: 8)

5.1 ± 1.7

5.9 ± 2.2

4.8 ± 1.2

7.0 ± 1.4

Group 4 (n: 7)

5.3 ± 1.4

4.0 ± 1.4

4.4 ± 1.6

7.9 ± 3.5

Group 5 (n: 8)

5.8 ± 1.3

3.9 ± 1.0

4.9 ± 2.0

6.6 ± 3.3

Group 6 (n: 8)

10.3 ± 3.0

5.3 ± 2.1

5.3 ± 2.8

8.1 ± 2.4

p-value

<0.001a

0.263b

0.584b

0.023b

Values are presented as mean ± SD, median (interquartile range), n: number.P-values were calculated with aone-way ANOVA or
b
Kruskal–Wallis test. The significant pairwise group comparison results were as represented below:
For primordial follicle count: 2 vs. 6: P = 0.0002, 3 vs. 6: P = 0.0005, 4 vs. 6: P = 0.0012, 5 vs. 6: P = 0.0027 (post hoc test: Tukey HSD)
For tertiary follicle count: 1 vs. 2: P = 0.003 (Mann–Whitney U test with Bonferroni correction)

following an ischemic insult in rats, based on the
histopathological and biochemical ﬁndings including
malondialdehyde, glutathione, and xanthine oxidase [19].
Similarly, malondialdehyde, myeloperoxidase, glutathione,
glutathione peroxidase, glutathione reductase, glutathione
s-transferase, and superoxide dismutase were found to
be significantly improved by 2.2 mg/kg i.p. melatonin in
the third study [20]. Moreover, it has been reported that
melatonin decreased cat ovarian [21] and rat uterine [22]
tissue injury after detorsion.
In our current study, rats were divided into 6 groups:
the sham group; the torsion/detorsion group; 3 melatonin
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(10 mg/kg i.p.) groups (only before torsion as a single dose
in the prophylaxis group; only after detorsion daily for 1
week in the maintenance group; and both before torsion
and after detorsion daily for 1 week in the prophylaxis plus
maintenance group, respectively).
The rationale behind scheming our melatonin groups
as the prophylaxis, maintenance, and prophylaxis plus
maintenance groups in our study was to mimic real clinical
scenarios in which a patient attends with the suspicion of
adnexal torsion, (i) the physician can give the therapeutic
agent before detorsion for prophylactic treatment, (ii)
the physician can give the therapeutic agent only after

KALYONCU et al. / Turk J Med Sci

Figure 2. Histological sections of rat ovaries stained with hematoxylin and eosin (H&E): a) normal ovarian morphology with normal
ovarian cortical and follicular architecture in the sham group (Group 1), H&E×200, b) vascular congestion, hemorrhage and edema
increased in the torsion/detorsion group (Group 2), H&E×200, c) mild vascular congestion hemorrhage and edema in the torsion/
detorsion + melatonin group (Group 5), H&E×200, d) ovarian follicle without follicular degeneration in sham group (Group 1),
H&E×200, e) ovarian follicle with prominent follicular degeneration in torsion/detorsion group (Group 2), H&E×200, f) ovarian
follicle with mild follicular degeneration in torsion/detorsion + melatonin group (Group 6), H&E×200.

detorsion as a maintenance treatment, or (iii) the physician
can give the therapeutic agent not only before detorsion
for prophylactic treatment, but also daily after detorsion
for a while for maintenance treatment (prophylaxis plus
maintenance treatment). However, there was no significant
difference between these treatment groups.
The results of this study have shown that melatonin
reduced ischemia reperfusion damage in the rat ovary
by histopathological and biochemical parameters as
shown for the third time in the literature. However, our
study is the first in the literature to show that melatonin
prevented ischemia reperfusion in a rat ovarian torsion/
detorsion model by improving oxidative stress in both
tissue and serum levels of peroxynitrite and serum levels
of OSI. Moreover, the melatonin group had a significantly
higher primordial follicle count than the surgical control
group.
This study has several limitations. An experimental
rat model of ovarian torsion/detorsion cannot really
exemplify the classical pathophysiology in clinical
practice in humans. In addition, there is no consensus
on the optimal dose and optimal duration of treatment
with melatonin. Moreover, a 7-day follow-up period
corresponds to a length of approximately 2 menstrual
cycles, as the estrous cycle of the rats takes about 4–5 days.

However, it would be improved if the rats were followed
up with for a longer period of time. Furthermore, it
would be better to measure primordial follicle count to
see the effects of ischemia reperfusion injury. Rotation
of the pedicle may not be needed to induce ischemia
reperfusion injury after vascular clip usage, as it might
have caused vascular injury in this experimental model.
Additionally, intraperitoneal alcohol is known as a
sclerosing agent, but it was demonstrated that even
intraperitoneal 99.9% ethanol had no more severe side
effects [42]. Moreover, the ethanol used in this study
was only 5% in concentration. Thus, further prospective
animal and even human studies are needed to determine
the value of melatonin for protecting ovaries from
ischemia reperfusion injury after detorsion.
All in all, our results show that melatonin exerts
protective effects against ischemia reperfusion
injury in a rat torsion/detorsion model by improving
histopathological and biochemical findings, including
primordial follicle count, tissue and serum levels of
peroxynitrite, and serum levels of oxidative stress index.
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